Fireside Chat: Commercial Trends & Opportunities in Retinal Imaging Biomarkers & Endpoints
Time: 1:00 pm
day: Conference Day Two
Details:
- Examine the evolving landscape of retinal imaging biomarkers in AMD, focusing on advancements in detecting disease progression and treatment efficacy
- Analyze unmet needs and opportunities for innovation, emphasizing the potential of novel imaging technologies and AI-driven analyses to enhance precision, durability, and patient care
- Explore collaboration across research and industry to standardize biomarkers and accelerate their clinical utility
